Concepts in risk-benefit assessment. A simple merit analysis of a medicine?

Drug Safety

Volumn 15, Issue 1, 1996, Pages 1-7

  Edwards, I Ralph ^a   Wiholm, Bengt Erik ^b   Martinez, Carlos ^c  

^a WHO Collaborating Ctr Intl Drug M   (Sweden)

^b MEDICAL PRODUCTS AGENCY   (Sweden)

^c SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG SAFETY; HUMAN; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS;

EID: 0030004351     PISSN: 01145916     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002018-199615010-00001     Document Type: Review

References (3)

1. Bullinger M. Indices versus profiles: advantages and disadvantages. In: Walker SR, Rosser RM, editors. Quality of life assessment. Dordrecht: Kluwer, 1993: 209-20
2. FASS Läkemedel i Sverige. Stockholm, Sweden: LINFO Läkemedels-information AB, 1995
3. CIOMS Working Group III. Guidelines for preparing core clinical safety information on drugs. Geneva: WHO, 1995